We are live on ! Find out more
OLVIG

Oliver Lagore Vanvalin Investment Group Portfolio holdings

AUM $255M
This Fund
S&P 500
This Quarter Est. Return
+8.9%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$341M
AUM Growth
+$71.9M
Cap. Flow
+$49.3M
Cap. Flow %
14.45%
Top 10 Hldgs %
50.13%
Holding
855
New
89
Increased
170
Reduced
184
Closed
121

Sector Composition

Rank Sector Weight
1 Technology 8.81%
2 Consumer Discretionary 3.53%
3 Healthcare 2.85%
4 Industrials 2.4%
5 Communication Services 2.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UL icon
501
Unilever
UL
$133B
$5.29K ﹤0.01%
94
+1
+1% +$55
ROAD icon
502
Construction Partners
ROAD
$6.9B
$5.28K ﹤0.01%
94
WTW icon
503
Willis Towers Watson
WTW
$31.6B
$5.22K ﹤0.01%
19
+12
+171% +$3.16K
NICE icon
504
Nice
NICE
$5.78B
$5.21K ﹤0.01%
20
+18
+900% +$4.08K
JQC icon
505
Nuveen Credit Strategies Income Fund
JQC
$717M
$5.2K ﹤0.01%
+933
New +$5.05K
FHLC icon
506
Fidelity MSCI Health Care Index ETF
FHLC
$3.42B
$5.16K ﹤0.01%
74
DJT icon
507
Trump Media & Technology Group
DJT
$2.3B
$5.14K ﹤0.01%
83
+65
+361% +$2.52K
NLY icon
508
Annaly Capital Management
NLY
$17.4B
$5.04K ﹤0.01%
+256
New +$4.94K
VRTX icon
509
Vertex Pharmaceuticals
VRTX
$133B
$5.02K ﹤0.01%
12
VALE icon
510
Vale
VALE
$61.4B
$4.94K ﹤0.01%
405
+7
+2% +$94
TFLO icon
511
iShares Treasury Floating Rate Bond ETF
TFLO
$6.72B
$4.87K ﹤0.01%
96
-8,173
-99% -$413K
BP icon
512
BP
BP
$111B
$4.82K ﹤0.01%
128
PHYS icon
513
Sprott Physical Gold
PHYS
$16B
$4.79K ﹤0.01%
277
-271
-49% -$4.35K
PFE icon
514
Pfizer
PFE
$150B
$4.72K ﹤0.01%
170
-28
-14% -$777
BALL icon
515
Ball Corp
BALL
$16.4B
$4.71K ﹤0.01%
70
UTF icon
516
Cohen & Steers Infrastructure Fund
UTF
$3B
$4.71K ﹤0.01%
200
ON icon
517
ON Semiconductor
ON
$32.4B
$4.71K ﹤0.01%
64
MYGN icon
518
Myriad Genetics
MYGN
$309M
$4.69K ﹤0.01%
+220
New +$4.73K
ALC icon
519
Alcon
ALC
$35.6B
$4.66K ﹤0.01%
56
XYZ
520
Block Inc
XYZ
$47B
$4.65K ﹤0.01%
55
-35
-39% -$2.53K
QRVO icon
521
Qorvo
QRVO
$8.67B
$4.59K ﹤0.01%
40
DT icon
522
Dynatrace
DT
$14.3B
$4.5K ﹤0.01%
97
-30
-24% -$1.56K
HLN icon
523
Haleon
HLN
$43.2B
$4.44K ﹤0.01%
523
VXX icon
524
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$141M
$4.44K ﹤0.01%
86
VIPS icon
525
Vipshop
VIPS
$6.94B
$4.43K ﹤0.01%
268

Similar funds

Oliver Lagore Vanvalin Investment Group's Q1 2024 Portfolio in Review

As of Q1 2024, Oliver Lagore Vanvalin Investment Group held 855 positions worth $341M, up 27% from $269M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Oliver Lagore Vanvalin Investment Group deployed $49.3M of net new capital in Q1 2024, opening 89 new positions and adding to 170 existing holdings. Its largest new stake was Tema ETF Trust Tema Heart & Health ETF: 122,203 shares worth $4.18M.

By sector, the portfolio is most concentrated in Technology at 8.8% of assets, up from 7.1% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was iShares 0-3 Month Treasury Bond ETF, an estimated $8.02M trimmed.

  • Oliver Lagore Vanvalin Investment Group's largest Q1 2024 buy was Tema ETF Trust Tema Heart & Health ETF: 122,203 shares worth $4.18M.
  • Oliver Lagore Vanvalin Investment Group added most to Invesco S&P 500 Equal Weight ETF in Q1 2024, an estimated $12.4M increase.
  • Oliver Lagore Vanvalin Investment Group's biggest Q1 2024 reduction was iShares 0-3 Month Treasury Bond ETF, cutting an estimated $8.02M.
  • Oliver Lagore Vanvalin Investment Group fully exited Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF in Q1 2024, selling an estimated $1.6M.
  • Oliver Lagore Vanvalin Investment Group's ten largest holdings make up 50% of its $341M portfolio in Q1 2024.
  • Oliver Lagore Vanvalin Investment Group opened 89 new positions and closed 121 in Q1 2024.
  • Oliver Lagore Vanvalin Investment Group's portfolio value rose 27% quarter-over-quarter to $341M.

Based on Oliver Lagore Vanvalin Investment Group's 13F filing for Q1 2024, filed 15 May 2024.